HCW Biologics Inc. is a clinical-stage biopharmaceutical company developing fusion immunotherapeutics to treat diseases driven by chronic inflammation, including autoimmune disorders, cancer, and senescence-associated dysplasia. The company uses two proprietary platforms, TOBI and TRBC, to engineer multi-functional fusion proteins. Lead candidates include HCW9302 (IL-2 fusion protein in clinical trial for alopecia areata), HCW11-018b (T-cell engager), HCW11-040 (cytokine/pembrolizumab fusion), and commercial-ready reagents HCW9206 and HCW9201 for CAR-T and NK cell therapy manufacturing.
Q2 FY2026 — expected 2026-09-13
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-31 | 2025-12-31 | 0001193125-26-134934 | EDGAR | 109K words |
| 2025-03-28 | 2024-12-31 | 0000950170-25-046724 | EDGAR | 96K words |
| 2024-04-01 | 2023-12-31 | 0000950170-24-039384 | EDGAR | 80K words |
| 2023-03-28 | 2022-12-31 | 0000950170-23-010315 | EDGAR | — |
| 2022-03-29 | 2021-12-31 | 0000950170-22-004847 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-14 | 2026-06-30 | 0001493152-26-038262 | EDGAR | 42K words |
| 2025-11-14 | 2025-09-30 | 0001193125-25-283238 | EDGAR | 44K words |
| 2025-08-18 | 2025-06-30 | 0000950170-25-109642 | EDGAR | 38K words |
| 2025-05-15 | 2025-03-31 | 0000950170-25-072833 | EDGAR | 29K words |
| 2024-11-14 | 2024-09-30 | 0000950170-24-127198 | EDGAR | 28K words |
| 2024-08-14 | 2024-06-30 | 0000950170-24-097121 | EDGAR | 25K words |
| 2024-05-15 | 2024-03-31 | 0000950170-24-060599 | EDGAR | 18K words |
| 2023-11-14 | 2023-09-30 | 0000950170-23-063359 | EDGAR | 19K words |
| 2023-08-11 | 2023-06-30 | 0000950170-23-041607 | EDGAR | 18K words |
| 2023-05-09 | 2023-03-31 | 0000950170-23-019142 | EDGAR | — |
| 2022-11-07 | 2022-09-30 | 0000950170-22-022697 | EDGAR | — |
| 2022-08-12 | 2022-06-30 | 0000950170-22-017015 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-09-24 | 0001493152-26-044078 | EDGAR | 1K words |
| 2026-09-10 | 0001493152-26-042009 | EDGAR | 1K words |
| 2026-09-08 | 0001493152-26-041716 | EDGAR | 1K words |
| 2026-08-14 | 0001493152-26-038258 | EDGAR | 4K words |
| 2026-08-14 | 0001493152-26-038240 | EDGAR | 1K words |
| 2026-07-29 | 0001493152-26-035233 | EDGAR | 1K words |
| 2026-03-31 | 0001193125-26-134936 | EDGAR | 4K words |
| 2026-03-17 | 0001193125-26-109407 | EDGAR | 1K words |
| 2026-03-02 | 0001193125-26-084291 | EDGAR | 1K words |
| 2026-02-19 | 0001193125-26-059578 | EDGAR | 1K words |
127 total filings indexed. 100 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001828673 |
| Ticker | HCWB |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.hcwbiologics.com |
| Listed | 2021-07-20 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/HCWB (~200 tokens, structured JSON with cryptographic provenance)